BCI
AXSM icon

Brinker Capital Investments’s Axsome Therapeutics AXSM Stock Holding History

Brinker Capital Investments’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,536
Closed -$260K – 1881
2026
Q1 		$260K Sell
1,536
-147
-9% -$25.4K ﹤0.01% 1723
2025
Q4 		$307K Sell
1,683
-506
-23% -$70.6K ﹤0.01% 1802
2025
Q3 		$266K Buy
2,189
+53
+2% +$5.97K ﹤0.01% 1829
2025
Q2 		$223K Sell
2,136
-130
-6% -$13.8K ﹤0.01% 1839
2025
Q1 		$264K Buy
+2,266
New +$258K ﹤0.01% 1683
2024
Q4 		– Sell
-2,751
Closed -$247K – 1826
2024
Q3 		$247K Sell
2,751
-53
-2% -$4.63K ﹤0.01% 1615
2024
Q2 		$226K Sell
2,804
-179
-6% -$13.3K ﹤0.01% 1581
2024
Q1 		$238K Buy
2,983
+60
+2% +$5.04K ﹤0.01% 1550
2023
Q4 		$260K Sell
2,923
-440
-13% -$29.4K ﹤0.01% 1467
2023
Q3 		$235K Buy
3,363
+19
+0.6% +$1.42K ﹤0.01% 1488
2023
Q2 		$240K Buy
+3,344
New +$247K ﹤0.01% 1493
2023
Q1 		– Sell
-2,681
Closed -$207K – 1559
2022
Q4 		$207K Sell
2,681
-3,305
-55% -$198K ﹤0.01% 1284
2022
Q3 		$267K Buy
+5,986
New +$299K 0.01% 1165
2021
Q1 		– Sell
-4,507
Closed -$367K – 1170
2020
Q4 		$367K Buy
+4,507
New +$337K 0.01% 900

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Brinker Capital Investments's AXSM Position: Q2 2026 in Review

Brinker Capital Investments sold out of Axsome Therapeutics (AXSM) in Q2 2026, closing a stake of 1,536 shares — an estimated $260K sold.

Brinker Capital Investments first reported a position in AXSM in Q4 2020 and held it in 14 quarters. The position peaked at $367K in Q4 2020. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Brinker Capital Investments reported no remaining Axsome Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Brinker Capital Investments sold 1,536 Axsome Therapeutics shares in Q2 2026, an estimated $260K.
  • Brinker Capital Investments first reported a position in Axsome Therapeutics in Q4 2020 and held it in 14 quarters.
  • Brinker Capital Investments's Axsome Therapeutics position peaked at $367K in Q4 2020.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Brinker Capital Investments's 13F filing for Q2 2026, filed 14 Aug 2026.